Your browser doesn't support javascript.
loading
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.
James, Elizabeth C; Dunn, David; Cook, Adrian D; Clamp, Andrew R; Sydes, Matthew R.
Afiliação
  • James EC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK. e.james@ucl.ac.uk.
  • Dunn D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Clamp AR; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK.
  • Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
Trials ; 21(1): 802, 2020 Sep 17.
Article em En | MEDLINE | ID: mdl-32943106
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article